Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Lignocellulosic biomass is a flexible renewable useful resource for fuels, buildings, crafts, and biomaterials. Strategies of molecularly designing lignocellulose for industrial software has been developed by the discoveries of novel genes after the screenings of varied mutants and remodeled traces of Arabidopsis whose cell partitions might be modified in the inflorescence stem, a mannequin woody tissue. The mechanical properties are used as a quantitative index for the chemorehological conduct of the genetically modified cell wall in the tissue.

This parameter could be measured with tensile or bending checks of tissue explants, the vibration evaluation of tissue conduct or utilizing atomic power microscopy to probe the tissue floor. Here, we describe in element the process to find out the stiffness of methanol-fixed, rehydrated and pronase-treated inflorescence explants with a tensile testing machine primarily based on classical strategies for the dedication of cell wall extensibility.

Extracellular matrix (ECM)-based tissue engineering scaffolds have a necessary position in selling tissue regeneration. Nerve tissue engineering goals at facilitating the restore of everlasting injury to the peripheral and central nervous methods, that are tough to heal. For this function, a range of biomaterials are being developed consisting of quite a few artificial and/or pure polymers to offer axonal reinnervation and to direct the development of axons. Here, we current a novel protocol that permits to manufacture a three-d (3D) decellularized scaffold derived from the bovine spinal twine (BSC) ECM (3D-dCBS) for neural tissue engineering purposes.

In this protocol, a viscous ECM-derived gel from BSC is ready, molded, and chemically crosslinked with EDC/NHS (3D-CBS) earlier than decellularization course of. Decellularization of 3D-CBS is carried out with 1% SDS to realize 3D-dCBS. As in contrast with different out there strategies, our protocol is a novel decellularization technique that preserves a extra important half of the ECM. We imagine that the talked about protocol has the potential to supply a bioengineered scaffold from spinal twine tissue with desired geometry for regenerative drugs purposes associated to neural tissue engineering.

The Fabrication of Poly( Σ-caprolactone)-Poly(ethylene oxide) Sandwich Type Nanofibers Containing Sericin-Capped Silver Nanoparticles as an Antibacterial Wound Dressing

In this examine, antibacterial, artificial poly(Σ-caprolactone)-poly(ethylene oxide) (PCL-PEO) multilayer nanofibers had been produced by an electrospinning technique. The materials was synthesized in Three layers. The upper-lower protecting layers had been produced by PCL nanofibers and the intermediate layer was produced from PEO nanofiber containing sericin-capped silver nanoparticles (S-AgNPs). The electrospinning circumstances in which nano-sized, clean, bead-free fibers had been obtained was decided to be an utilized voltage of 20 kV, a circulate price of 8 μL/min and a distance between the collector and the needle tip of 22 cm for the PCL layer (dissolved at a 12% g/mL focus in a chloroform:methanol (3:2) solvent combination) layer.

For the S-AgNPs doped PEO layer (dissolved at a 3.5% g/mL focus in water), the corresponding circumstances had been decided to be 20 kV, 15 μL/min and 20 cm.To characterize the three-layer materials that consisted of PCL and S-AgNPs doped PEO layers, FTIR and SEM analyses had been carried out, and the water retention capability, in situ degradability and antibacterial exercise of the materials was investigated.

According to SEM evaluation, the fibers obtained had been discovered to be nano-sized, clean and bead-free and the common measurement of the nanofibers forming the PCL layer was 687 nm whereas the common measurement of the fibers forming the PEO layer was 98 nm. Antibacterial exercise checks had been carried out utilizing gram-positive (Staphylococcus aureus ATCC 6538) and gram-negative (Escherichia coli ATCC 25922) micro organism and the ensuing biomaterial was discovered to have antimicrobial impact on each gram-negative and gram-positive micro organism. It was decided that the 3-layer materials obtained in this examine can be utilized as a wound dressing.

 Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Peptide-Chitosan Engineered Scaffolds for Biomedical Applications

Peptides are signaling epitopes that management many important organic occasions. Increased specificity, artificial feasibility with concomitant lack of toxicity, and immunogenicity make this rising class of biomolecules appropriate for totally different purposes together with therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of d-glucosamine and N-acetyl-d-glucosamine items, possesses anti-microbial, muco-adhesive, and hemostatic properties together with wonderful biocompatibility.

As a end result, chitosan finds software in drug/gene supply, tissue engineering, and bioimaging. Despite these purposes, chitosan demonstrates restricted cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a brand new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a end result, current research embody elevated software of peptide-chitosan hybrids as composites or conjugates in drug supply, cell remedy, and tissue engineering and as anti-microbial materials. This evaluate discusses the current investigations involving chitosan-peptide supplies and uncovers varied facets of these attention-grabbing hybrid supplies for biomedical purposes.

Tetanus Toxoid scFv Antibody

abx137499-100tests 100 tests
EUR 225

FMC63 scFv, His Tag (SPR verified)

CD9-M52Hb 100ug
EUR 1487.3
Description: FMC63 scFv, His Tag (CD9-M52Hb) is expressed from human 293 cells (HEK293). It mimics the scFv presented on CAR-T cells which target CD19.

Recombinant (E.Coli) Anti-p53 scFv IgG

RP-341 10 ug
EUR 343.2

pHrdSV40- scFv- GCN4- sfGFP- VP64- GB1- NLS

PVT10950 2 ug
EUR 361.2

Anti-TNFRSF8 (clone Ki4) scFv-MAP ADC

ADC-W-354 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (clone Ki4) conjugated via a linker to a MAP

Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgG

RP-343 10 ug
EUR 343.2

Anti-ROR1 (clone R11) scFv-Fc-Sec ADC

ADC-W-434 1mg Ask for price
Description: This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug

SARS-CoV-2 Nucleocapsid Protein scFv Antibody

abx229488-100g 100 µg
EUR 1725

Anti-COVID-19 Nucleocapsid Protein scFv Antibody

E38A9964 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Biotinylated FMC63 scFv, Fc,Avitag™ (MALS verified)

CD9-BV4324b 25ug
EUR 1294.7
Description: Biotinylated FMC63 scFv, Fc, Avitag is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain.

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56

CABT-Z294M 25 tests; 250 tests Ask for price
Description: Mouse

E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody

DL99719A-100ul 100 ul
EUR 299
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N

E.coli anti-COVID-19 Nucleocapsid Protein scFv Antibody

DL99719A-50ul 50 ul
EUR 210
Description: Nucleoprotein; Nucleocapsid protein; NC; Protein N

SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV)

E-AB-V1012-1mg 1mg
EUR 9200
Description: Unconjugated

SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV)

E-AB-V1012-each each Ask for price
Description: Unconjugated

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [PE]

CABT-Z293M 25 tests
EUR 840
Description: Mouse

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [FITC]

CABT-Z296M 25 tests; 200 tests Ask for price
Description: Mouse

Mouse Anti-FMC63 scFv Monoclonal Antibody, clone Z56 [Biotin]

CABT-Z295M 25 tests; 200 tests Ask for price
Description: Mouse

Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ)

78600 50 µl
EUR 1150
Description: The anti-CD19 CAR lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express the ScFv portion of anti-CD19 (clone FMC63) linked to 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge, 4-1BB, and CD3ζ signaling domains. 

AS Control

A26 -
EUR 330
Description: SW module for AS control

GC Control

A23 -
EUR 600
Description: SW module for GC control

LC Control

A24 -
EUR 600
Description: SW module for HPLC/CE control (pump, det, etc.)

Rat Control

DEV99RC 2 x 1 ml
EUR 60

MDP control

tlrl-mdpcl 5 mg
EUR 148.05

Rat neurofascin (Nfasc)-control Control/blocking peptide

AB-23249-CP 100ug
EUR 196.8

pMD18- Control

PVT10563 2 ug
EUR 319.2

pMD19- Control

PVT10564 2 ug
EUR 319.2

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 242.4

Control Slides

24012-1 1box
EUR 78

Canine Control

DEV99CC 2 x 1 ml
EUR 60

Dengue Control

ant-543 100µg
EUR 165
Description: Mouse Anti-Dengue Control for Lateral Flow Test

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 196.8

Quality Control

abx098966-1vial 1 vial
EUR 360

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 196.8

PIPET CONTROLLER CONTROL BOARD

357484 1/pk
EUR 104.4
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 123.6

ODN 2088 control

tlrl-2088c-1 1 mg
EUR 546

ODN 2395 control

tlrl-2395c-1 1 mg
EUR 546

Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control

TYROSIN081 1.5mm
EUR 50

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Control siRNA Vector (pGB-control)

9500C-20 each
EUR 405.6

Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv)

E24CHA691 100 μg
EUR 225
Description: Available in various conjugation types.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

OOSA10387-100T - IgM NEGATIVE CONTROL Negative/Isotype Control

OOSA10387-100T 100Tests
EUR 309

OOSA10342-100UG - IgG1 NEGATIVE CONTROL Negative/Isotype Control

OOSA10342-100UG 0.1mg
EUR 219

OOSA10349-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10349-100T 100Tests
EUR 299

OOSA10380-100T - IgG2b NEGATIVE CONTROL Negative/Isotype Control

OOSA10380-100T 100Tests
EUR 309

OOSA10389-100T - IgG1 NEGATIVE CONTROL Negative/Isotype Control

OOSA10389-100T 100Tests
EUR 309

OOSA10397-100T - IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10397-100T 100Tests
EUR 309

Control FD BNP

K023M-6 6 x 1 mL
EUR 292
Description: Bi-Level

Control FD TDM

K068M-6 6 x 5 mL
EUR 205
Description: Tri-Level

Anti-CD22 CAR Lentivirus (Clone m971 ScFv-CD8-4-1BB-CD3ζ)

78608 50 µl
EUR 1095
Description: The anti-CD22 CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-CD22 (clone m971) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (below).

Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control

MAMA-G081 1.5mm
EUR 50

EDG-1 Control

BC-009 100 uL
EUR 350

EDG-2 Control

BC-011 100 uL
EUR 350

EDG-4 Control

BC-012 100 uL
EUR 350

EDG-6 Control

BC-014 100 uL
EUR 350

EDG-7 Control

BC-016 100 uL
EUR 350

Rat Control IgG

AC034 100 ul
EUR 159.6

β-Gal Control

LV007 4 x 500 ul
EUR 195

NF-κB Control

T37559-10mg 10mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-1g 1g Ask for price
Description: NF-κB Control

NF-κB Control

T37559-1mg 1mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-50mg 50mg Ask for price
Description: NF-κB Control

NF-κB Control

T37559-5mg 5mg Ask for price
Description: NF-κB Control

Anti-BCMA CAR Lentivirus (Clone C11D5.3 ScFv-CD8-4-1BB-CD3ζ)

78655 50 µl
EUR 1095
Description: The anti-BCMA CAR lentiviruses are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv (single-chain variable fragment) of anti-BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). The lentiviruses also transduce a puromycin selection gene.

Goat IgG control

31R-AG001 1 mg
EUR 104
Description: Goat Immunoglobulins Goat IgG control

Goat IgG Control

GT15900 1 mg
EUR 199.2

2'3'-cGAMP Control

tlrl-nagpap 1 mg
EUR 235.2

G3-YSD Control

tlrl-ydnac 200 µg
EUR 148.05

Rat IgG1 Control

mabg1-ctlrt 100 µg Ask for price

MG-BSA Control

STA-306 100 µg
EUR 386.4
Description:
  • Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL

Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control

GCDFP081 1.5mm
EUR 50

Mouse IgG Control

10R-I169A 250 ug
EUR 104
Description: Mouse Immunoglobulins Mouse IgG Control

human IgM control

E4A11C04 50ug
EUR 255
Description: Available in various conjugation types.

human IgE control

E4A11C05 50ug
EUR 255
Description: Available in various conjugation types.

Mouse Control IgG

AC011 100 ul
EUR 143
Description: None

Mouse IgM Control

ICIGMF-100 100 µg
EUR 239.4

Mouse IgM Control

ICIGMPU-100 100 µg
EUR 239.4

ISD Control Naked

tlrl-isdcn 200 µg
EUR 148.05

Rat IgG2a Control

mabg2a-ctlrt 100 µg
EUR 101.85

Rat IgG2a Control

mabg2a-ctlrt-05 5 x 100 µg
EUR 163.8

Rat IgG2b Control

mabg2b-ctlrt 100 µg Ask for price

CEL-BSA Control

STA-302 100 µg
EUR 245

CML-BSA Control

STA-314 100 µg
EUR 386.4
Description:
  • CML-BSA may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

MDA-BSA Control

STA-333 100 µg
EUR 245

HNE-BSA Control

STA-335 100 µg
EUR 245

human IgM control

E4A11D04 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human IgE control

E4A11D05 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

OOSA10361-1ML - Rat IgG2a NEGATIVE CONTROL Negative/Isotype Control

OOSA10361-1ML 1ml
EUR 169

Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control

MSH2081 1.5mm
EUR 50

Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control

OLIG2081 1.5mm
EUR 50

Rabbit IgG Control

31R-AR001 500 ug
EUR 94
Description: Purified Normal Rabbit IgG

human IgG1 control

E4A11C03 50ug
EUR 255
Description: Available in various conjugation types.

Rabbit Control IgG

AC005 100 ul
EUR 143
Description: A synthetic peptide corresponding to Actin (plant specific).

Human IgG1 Control

HY-P9900 5mg
EUR 776.4

Mouse IgG1 Control

ICIGG1AC750-50 50 µg
EUR 855.6

Mouse IgG1 Control

ICIGG1PU-100 100 µg
EUR 239.4

Mouse IgG3 Control

ICIGG3CFB-100 100 µg
EUR 465.6

CD3 Control Slides

ICS2005-25 25 Slides
EUR 137.81

CD5 Control Slides

ICS2006-25 25 Slides
EUR 137.81

CD8 Control Slides

ICS2007-25 25 Slides
EUR 137.81

CEA Control Slides

ICS2012-25 25 Slides
EUR 137.81

EMA Control Slides

ICS2018-25 25 Slides
EUR 137.81

LCA Control Slides

ICS2029-25 25 Slides
EUR 137.81

NSE Control Slides

ICS2031-25 25 Slides
EUR 137.81

PSA Control Slides

ICS2033-25 25 Slides
EUR 137.81

PAS Control Slides

HCS1016-25 25 Slides
EUR 137.81

Rabbit IgG Control

GWB-DLRABG 0.5 mg Ask for price

ODN TTAGGG control

tlrl-ttagc-1 1 mg
EUR 546

Human IgA2 Control

maba2-ctrl 100 µg
EUR 101.85

Human IgA2 Control

maba2-ctrl-05 5 x 100 µg
EUR 163.8

Mouse Control IgG1

mabg1-ctrlm 100 µg
EUR 99.75

Mouse Control IgG1

mabg1-ctrlm-05 5 x 100 µg
EUR 163.8

Due to the lack of vascular distribution and the sluggish metabolism, cartilage tissue can’t restore itself, which stays an enormous problem for cartilage regeneration. Tissue engineering utilizing stem cells seems to be a promising technique for cartilage restore. Tissue engineers demonstrated that mechanical stimulation can improve the high quality of engineered cartilage, making it extra much like pure cartilage in construction and performance. In this evaluate, we summarize current research on the position of mechanical stimuli in chondrogenesis, specializing in the purposes of extrinsic mechanical loading and the research on mechanical properties of biomaterials in cartilage tissue engineering. This evaluate will present contemporary insights into the potential use of mechanical stimuli for scientific use.


Machine learning active-nematic hydrodynamics

Machine learning active-nematic hydrodynamics

Hydrodynamic theories successfully describe many-body programs out of equilibrium when it comes to just a few macroscopic parameters. However, such parameters are troublesome to find out from microscopic data. Seldom is that this problem extra obvious than in lively matter, the place the hydrodynamic parameters are actually fields that encode the distribution of energy-injecting microscopic parts. Here, we use lively nematics to reveal that neural networks can map out the spatiotemporal variation of a number of hydrodynamic parameters and forecast the chaotic dynamics of those programs.

We analyze biofilament/molecular-motor experiments with microtubule/kinesin and actin/myosin complexes as laptop imaginative and prescient issues. Our algorithms can decide how exercise and elastic moduli change as a operate of area and time, in addition to adenosine triphosphate (ATP) or motor focus. The solely enter wanted is the orientation of the biofilaments and never the coupled velocity subject which is tougher to entry in experiments. We may also forecast the evolution of those chaotic many-body programs solely from picture sequences of their previous utilizing a mixture of autoencoders and recurrent neural networks with residual structure. In life like experimental setups for which the preliminary circumstances will not be completely identified, our physics-inspired machine-learning algorithms can surpass deterministic simulations.

Blending of various biopolymers, e.g., collagen, chitosan, silk fibroin and cross-linking modifications of those mixtures can result in new supplies with improved physico-chemical properties, in comparison with single-component scaffolds. Three-dimensional scaffolds based mostly on three-component mixtures of silk fibroin, collagen and chitosan, chemically cross-linked, have been ready and their physico-chemical and organic properties have been evaluated. A mix of EDC (N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride) and NHS (N-hydroxysuccinimide) was used as a cross-linking agent. FTIR was used to watch the place of the peaks attribute for collagen, chitosan and silk fibroin. The following properties relying on the scaffold construction have been studied: swelling conduct, liquid uptake, moisture content material, porosity, density, and mechanical parameters.

Scanning Electron Microscopy imaging was carried out. Additionally, the organic properties of those supplies have been assessed, by metabolic exercise assay. The outcomes confirmed that the three-component mixtures, cross-linked by EDC/NHS and ready by lyophilization methodology, offered porous constructions. They have been characterised by a excessive swelling diploma. The composition of scaffolds has an affect on mechanical properties. All of the studied supplies have been cytocompatible with MG-63 osteoblast-like cells. Our research paves the way in which for artificial-intelligence characterization and management of coupled chaotic fields in numerous bodily and organic programs, even within the absence of information of the underlying dynamics.

 Machine learning active-nematic hydrodynamics

Evaluating Whole Blood Clotting in vitro on Biomaterial Surfaces

Biomaterial-associated thrombosis continues to be a significant concern for blood-contacting implants. After the medical system is implanted and is available in contact with blood, a number of advanced reactions happen, which can result in thrombus formation and failure of the system. Therefore, it’s important to guage the biomaterial interplay with the entire blood. Several research have been reported within the literature that consider completely different steps within the coagulation cascade, resembling protein adsorption, plasma activation, and platelet adhesion in vitro, nonetheless, analysis of complete blood clotting on biomaterial surfaces is just not extensively reported.

Here, a protocol to guage complete blood clotting in vitro on 2D biomaterials surfaces by way of a easy and quick hemolysis assay is offered. Whole human blood is positioned onto the biomaterial surfaces and is allowed to clot for various time durations. After the particular time intervals, the surfaces are transferred into deionized (DI) water to launch the free hemoglobin and the absorbance of this answer is measured. The absorbance worth is proportional to the free hemoglobin focus within the DI water as a consequence of lysis of crimson blood cells and offers an oblique correlation to the extent of blood clotting on the biomaterial surfaces. This protocol offers a quick, facile and efficient methodology to measure the anti-thrombogenic properties of biomaterials.

Hamster IgG Isotype Control

GWB-1A8D7A 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-30C10C 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-3114BE 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-3413D0 0.1 mg Ask for price

Hamster IgG Isotype Control

GWB-6571A8 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-EE081F 0.5 mg Ask for price

Hamster IgG Isotype Control

GWB-C224BD 0.1 mg Ask for price

Syrian Hamster IgG Isotype Control

SIGGA-100 100 µg
EUR 688.99

Syrian Hamster IgG Isotype Control

SIGGB-200 200 µg
EUR 566.69

Syrian Hamster IgG Isotype Control

SIGGF-200 200 µg
EUR 654.05

Syrian Hamster IgG Isotype Control

SIGGPE-100 100 µg
EUR 619.1

Syrian Hamster IgG Isotype Control

SIGGPP5.5-100 100 µg
EUR 811.3

Syrian Hamster IgG Isotype Control

SIGGPP5.5-25 25 µg
EUR 426.91

Syrian Hamster IgG Isotype Control

SIGGPU-500 500 µg
EUR 514.27

Armenian Hamster IgG Isotype control

AIGGA-100 100 µg
EUR 688.99

Armenian Hamster IgG Isotype control

AIGGA-25 25 µg
EUR 339.55

Armenian Hamster IgG Isotype control

AIGGB-200 200 µg
EUR 566.69

Armenian Hamster IgG Isotype control

AIGGB-50 50 µg
EUR 287.14

Armenian Hamster IgG Isotype control

AIGGF-200 200 µg
EUR 654.05

Armenian Hamster IgG Isotype control

AIGGF-50 50 µg
EUR 322.08

Armenian Hamster IgG Isotype control

AIGGPE-100 100 µg
EUR 619.1

Armenian Hamster IgG Isotype control

AIGGPE-25 25 µg
EUR 304.61

Armenian Hamster IgG Isotype control

AIGGPP-100 100 µg
EUR 688.99

Armenian Hamster IgG Isotype control

AIGGPP-25 25 µg
EUR 322.08

Armenian Hamster IgG Isotype control

AIGGPP5.5-100 100 µg
EUR 776.35

Armenian Hamster IgG Isotype control

AIGGPP5.5-25 25 µg
EUR 339.55

Armenian Hamster IgG Isotype control

AIGGPU-50 50 µg
EUR 234.72

Armenian Hamster IgG Isotype control

AIGGPU-500 500 µg
EUR 514.27

Hamster (Syrian) IgG Isotype Control

abx405032-025mg 0.25 mg
EUR 460.8

PE Syrian Hamster IgG Isotype Control

DL22376F-20Tests 20Tests
EUR 158

PE Syrian Hamster IgG Isotype Control

DL22376F-50Tests 50Tests
EUR 233

PE Syrian Hamster IgG Isotype Control

DL22391F-25ug 25μg
EUR 137

PE Syrian Hamster IgG Isotype Control

DL22391F-50ug 50μg
EUR 182

Hamster (Armenian) IgG Isotype Control

abx405028-025mg 0.25 mg
EUR 460.8

Hamster (Arnenian) IgG Isotype Control

abx405029-05mg 0.5 mg
EUR 710.4

FITC Syrian Hamster IgG Isotype Control

DL22375F-20Tests 20Tests
EUR 158

FITC Syrian Hamster IgG Isotype Control

DL22375F-50Tests 50Tests
EUR 233

FITC Syrian Hamster IgG Isotype Control

DL22390F-25ug 25μg
EUR 137

FITC Syrian Hamster IgG Isotype Control

DL22390F-50ug 50μg
EUR 182

PE Armenian Hamster IgG Isotype Control

DL22565F-20Tests 20Tests
EUR 158

PE Armenian Hamster IgG Isotype Control

DL22565F-50Tests 50Tests
EUR 233

PE Armenian Hamster IgG Isotype Control

DL22580F-25ug 25μg
EUR 137

PE Armenian Hamster IgG Isotype Control

DL22580F-50ug 50μg
EUR 182

PE Armenian Hamster IgG Isotype Control

E16FTCP006-025U 25 μg
EUR 303.33
Description: Available in various conjugation types.

PE Armenian Hamster IgG Isotype Control

E16FTCP006-100U 100 μg
EUR 693.33
Description: Available in various conjugation types.

AF488 Syrian Hamster IgG Isotype Control

DL22384F-20Tests 20Tests
EUR 185

AF488 Syrian Hamster IgG Isotype Control

DL22384F-50Tests 50Tests
EUR 267.5

AF647 Syrian Hamster IgG Isotype Control

DL22385F-20Tests 20Tests
EUR 185

AF647 Syrian Hamster IgG Isotype Control

DL22385F-50Tests 50Tests
EUR 267.5

AF488 Syrian Hamster IgG Isotype Control

DL22399F-25ug 25μg
EUR 182

AF488 Syrian Hamster IgG Isotype Control

DL22399F-50ug 50μg
EUR 272

AF647 Syrian Hamster IgG Isotype Control

DL22400F-25ug 25μg
EUR 182

AF647 Syrian Hamster IgG Isotype Control

DL22400F-50ug 50μg
EUR 272

APC Armenian Hamster IgG Isotype Control

DL22566F-20Tests 20Tests
EUR 170

APC Armenian Hamster IgG Isotype Control

DL22566F-50Tests 50Tests
EUR 245

APC Armenian Hamster IgG Isotype Control

DL22581F-25ug 25μg
EUR 147.5

APC Armenian Hamster IgG Isotype Control

DL22581F-50ug 50μg
EUR 197

APC Armenian Hamster IgG Isotype Control

E16FTCA006-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

APC Armenian Hamster IgG Isotype Control

E16FTCA006-100U 100 μg
EUR 780
Description: Available in various conjugation types.

Biotin Syrian Hamster IgG Isotype Control

DL22389F-25ug 25μg
EUR 137

Biotin Syrian Hamster IgG Isotype Control

DL22389F-50ug 50μg
EUR 182

FITC Armenian Hamster IgG Isotype Control

DL22564F-20Tests 20Tests
EUR 158

FITC Armenian Hamster IgG Isotype Control

DL22564F-50Tests 50Tests
EUR 233

FITC Armenian Hamster IgG Isotype Control

DL22579F-25ug 25μg
EUR 137

FITC Armenian Hamster IgG Isotype Control

DL22579F-50ug 50μg
EUR 182

FITC Armenian Hamster IgG Isotype Control

E16FTCF006-200U 200 μg
EUR 736.67
Description: Available in various conjugation types.

AF647 Armenian Hamster IgG Isotype Control

DL22574F-20Tests 20Tests
EUR 185

AF647 Armenian Hamster IgG Isotype Control

DL22574F-50Tests 50Tests
EUR 267.5

AF488 Armenian Hamster IgG Isotype Control

DL22588F-25ug 25μg
EUR 182

AF488 Armenian Hamster IgG Isotype Control

DL22588F-50ug 50μg
EUR 272

AF647 Armenian Hamster IgG Isotype Control

DL22589F-25ug 25μg
EUR 182

AF647 Armenian Hamster IgG Isotype Control

DL22589F-50ug 50μg
EUR 272

PerCP Armenian Hamster IgG Isotype Control

E16FTCR006-025U 25 μg
EUR 325
Description: Available in various conjugation types.

PerCP Armenian Hamster IgG Isotype Control

E16FTCR006-100U 100 μg
EUR 780
Description: Available in various conjugation types.

Biotin Armenian Hamster IgG Isotype Control

DL22578F-25ug 25μg
EUR 137

Biotin Armenian Hamster IgG Isotype Control

DL22578F-50ug 50μg
EUR 182

Biotin Armenian Hamster IgG Isotype Control

E16FTCB006-200U 200 μg
EUR 628.33
Description: Available in various conjugation types.

Purified Armenian Hamster IgG Isotype Control

DL22577F-25ug 25μg
EUR 137

Purified Armenian Hamster IgG Isotype Control

DL22577F-50ug 50μg
EUR 182

Hamster (Syrian) IgG Isotype Control (FITC)

abx405033-01mg 0.1 mg
EUR 477.6

Hamster (Arnenian) IgG Isotype Control (RPE)

abx405031-01mg 0.1 mg
EUR 610.8

Armenian Hamster IgG Isotype Control (PE) [PIP]

E2781886 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852D-100Tests 100Tests
EUR 82
Description: FCM

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852D-100Tests2 100Tests×2
EUR 112
Description: FCM

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852D-20Tests 20Tests
EUR 32
Description: FCM

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853D-100ug 100ug
EUR 50
Description: FCM

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853D-25ug 25ug
EUR 21
Description: FCM

PE Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853D-each each Ask for price
Description: FCM

Hamster (Arnenian) IgG Isotype Control (FITC)

abx405030-01mg 0.1 mg
EUR 460.8

Armenian Hamster IgG Isotype Control (APC) [PIP]

E2781887 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852E-100Tests 100Tests
EUR 110
Description: FCM

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852E-100Tests2 100Tests×2
EUR 160
Description: FCM

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852E-20Tests 20Tests
EUR 40
Description: FCM

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853E-100ug 100ug
EUR 69
Description: FCM

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853E-25ug 25ug
EUR 30
Description: FCM

APC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853E-each each Ask for price
Description: FCM

Hamster IgG, purified (Syrian, isotype control)

20003-1 1 mg
EUR 169.2

PE-Cy5 Armenian Hamster IgG Isotype Control

E16FTCC006-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

PE-Cy5 Armenian Hamster IgG Isotype Control

E16FTCC006-100U 100 μg
EUR 780
Description: Available in various conjugation types.

PE-Cy7 Armenian Hamster IgG Isotype Control

E16FTCN006-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

PE-Cy7 Armenian Hamster IgG Isotype Control

E16FTCN006-100U 100 μg
EUR 650
Description: Available in various conjugation types.

Armenian Hamster IgG Isotype Control (FITC) [PIP]

E2781892 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852C-100Tests 100Tests
EUR 82
Description: FCM

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852C-100Tests2 100Tests×2
EUR 112
Description: FCM

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09852C-20Tests 20Tests
EUR 32
Description: FCM

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853C-100ug 100ug
EUR 50
Description: FCM

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853C-25ug 25ug
EUR 21
Description: FCM

FITC Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853C-each each Ask for price
Description: FCM

APC-Cy7 Armenian Hamster IgG Isotype Control

E16FTCO006-025U 25 μg
EUR 390
Description: Available in various conjugation types.

Armenian Hamster IgG Isotype Control (AF647) [PIP]

E2781891 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Armenian Hamster IgG Isotype Control (EV450) [PIP]

E2782069 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Armenian Hamster IgG Isotype Control (ER780) [PIP]

E2782089 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Hamster IgG, purified (Armenian, Isotype control)

20003-1AH 1 mg
EUR 315.6

Biotin Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853B-100ug 100ug
EUR 50
Description: FCM

Biotin Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853B-25ug 25ug
EUR 21
Description: FCM

Biotin Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853B-each each Ask for price
Description: FCM

PE/Cyanine7 Armenian Hamster IgG Isotype Control

DL22569F-20Tests 20Tests
EUR 185

PE/Cyanine7 Armenian Hamster IgG Isotype Control

DL22569F-50Tests 50Tests
EUR 267.5

PE/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22570F-20Tests 20Tests
EUR 185

PE/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22570F-50Tests 50Tests
EUR 267.5

PE/Cyanine7 Armenian Hamster IgG Isotype Control

DL22584F-25ug 25μg
EUR 182

PE/Cyanine7 Armenian Hamster IgG Isotype Control

DL22584F-50ug 50μg
EUR 272

PE/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22585F-25ug 25μg
EUR 182

PE/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22585F-50ug 50μg
EUR 272

PerCP-Cy5.5 Armenian Hamster IgG Isotype Control

E16FTCS006-100U 100 μg
EUR 888.33
Description: Available in various conjugation types.

NE Purified Armenian Hamster IgG Isotype Control

E16FTCY006-050U 50 μg
EUR 260
Description: Available in various conjugation types.

NE Purified Armenian Hamster IgG Isotype Control

E16FTCY006-1000U 1 mg
EUR 1516.67
Description: Available in various conjugation types.

NE Purified Armenian Hamster IgG Isotype Control

E16FTCY006-500U 500 μg
EUR 823.33
Description: Available in various conjugation types.

Syrian Hamster IgG Isotype Control (PE) [SHG-1]

E2781998 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762D-100Tests 100Tests
EUR 82
Description: FCM

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762D-100Tests2 100Tests×2
EUR 112
Description: FCM

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762D-20Tests 20Tests
EUR 32
Description: FCM

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763D-100ug 100ug
EUR 50
Description: FCM

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763D-25ug 25ug
EUR 21
Description: FCM

PE Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763D-each each Ask for price
Description: FCM

Syrian Hamster IgG Isotype Control(APC Conjugated)

DL22377F-20Tests 20 Tests
EUR 120

Syrian Hamster IgG Isotype Control(APC Conjugated)

DL22377F-50Tests 50 Tests
EUR 210

UNE Purified Armenian Hamster IgG Isotype Control

E16FTCZ006-1000U 1 mg
EUR 1581.67
Description: Available in various conjugation types.

UNE Purified Armenian Hamster IgG Isotype Control

E16FTCZ006-100U 100 μg
EUR 433.33
Description: Available in various conjugation types.

Purified Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853A-100ug 100ug
EUR 50
Description: FCM

Purified Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853A-25ug 25ug
EUR 21
Description: FCM

Purified Armenian Hamster IgG Isotype Control[PIP]

E-AB-F09853A-each each Ask for price
Description: FCM

Syrian Hamster IgG Isotype Control(PerCP Conjugated)

DL22378F-20Tests 20 Tests
EUR 150

Syrian Hamster IgG Isotype Control(PerCP Conjugated)

DL22378F-50Tests 50 Tests
EUR 255

Syrian Hamster IgG Isotype Control(PerCP Conjugated)

DL22393F-25ug 25 μg
EUR 144

Syrian Hamster IgG Isotype Control(PerCP Conjugated)

DL22393F-50ug 50 μg
EUR 264

Armenian Hamster IgG Isotype Control (PE/Cy7) [PIP]

E2781888 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Armenian Hamster IgG Isotype Control (PE/Cy5.5) [PIP]

E2781889 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Syrian Hamster IgG Isotype Control (FITC) [SHG-1]

E2781997 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762C-100Tests 100Tests
EUR 82
Description: FCM

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762C-100Tests2 100Tests×2
EUR 112
Description: FCM

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09762C-20Tests 20Tests
EUR 32
Description: FCM

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763C-100ug 100ug
EUR 50
Description: FCM

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763C-25ug 25ug
EUR 21
Description: FCM

FITC Syrian Hamster IgG Isotype Control[SHG-1]

E-AB-F09763C-each each Ask for price
Description: FCM

PerCP/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22571F-20Tests 20Tests
EUR 185

PerCP/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22571F-50Tests 50Tests
EUR 267.5

PerCP/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22586F-25ug 25μg
EUR 182

PerCP/Cyanine5.5 Armenian Hamster IgG Isotype Control

DL22586F-50ug 50μg
EUR 272

Syrian Hamster IgG Isotype Control (AF488) [SHG-1]

E2781999 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Syrian Hamster IgG Isotype Control (AF647) [SHG-1]

E2782000 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Syrian Hamster IgG Isotype Control (EV450) [SHG-1]

E2782072 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Normal hamster polyclonal isotype control IgG

nAP-0011 1mg
EUR 459

Armenian Hamster IgG Isotype Control(PerCP Conjugated)

DL22567F-20Tests 20 Tests
EUR 150

Spinal wire damage (SCI) usually ends in long-lasting useful deficits, largely as a consequence of major and secondary white matter injury on the website of damage. The transplantation of neural stem cells (NSCs) has proven promise for re-establishing communications between separated areas of the spinal wire by way of the insertion of latest neurons between the injured axons and goal neurons. However, the inhibitory microenvironment that develops after SCI usually causes endogenous and transplanted NSCs to distinguish into glial cells moderately than neurons. Functional biomaterials have been proven to mitigate the results of the antagonistic SCI microenvironment and promote the neuronal differentiation of NSCs.

A transparent understanding of the mechanisms of neuronal differentiation inside the injury-induced microenvironment would possible permit for the event of remedy methods designed to advertise the innate potential of NSCs to distinguish into neurons. The elevated differentiation of neurons might contribute to relay formation, facilitating useful restoration after SCI. In this assessment, we summarize present methods used to reinforce the neuronal differentiation of NSCs by way of the reconstruction of the SCI microenvironment and to enhance the intrinsic neuronal differentiation skills of NSCs, which is important for SCI restore.


Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

The use of decellularized extracellular matrix (dECM) as a biomaterial has been an vital step ahead for the event of purposeful tissue constructs. In addition to tissues and organs, cell cultures are gaining a lot of consideration as a substitute supply of dECM. In this work, a novel biomimetic hydrogel is developed primarily based on dECM obtained from mesenchymal stem cells (mdECM) for cartilage tissue engineering. To this finish, cells are seeded underneath particular tradition situations to generate an early chondrogenic extracellular matrix (ECM) offering cues and components essential for cartilage improvement.

The composition is decided by quantitative, histological, and mass spectrometry methods. Moreover, the decellularization course of is evaluated by measuring the DNA content material and compositional analyses, and the hydrogel is formulated at completely different concentrations (3% and 6% w/v). Results present that mdECM derived hydrogels possess glorious biocompatibility and appropriate physicochemical and mechanical properties for their injectability. Furthermore, it’s evidenced that this hydrogel is ready to induce chondrogenesis of mesenchymal stem cells (MSCs) with out supplemental components and, moreover, to kind hyaline cartilage-like tissue after in vivo implantation. These findings exhibit for the primary time the potential of this hydrogel primarily based on mdECM for functions in cartilage restore and regeneration.

Manufacturing macroscale cell-laden architectures is one of the most important challenges confronted these days within the area of tissue engineering. Such dwelling constructs, in reality, pose strict necessities for vitamins and oxygen provide that may hardly be addressed by means of easy diffusion in vitro or with out a purposeful vasculature in vivo. In this context, within the final twenty years, a substantial quantity of work has been carried out to develop sensible supplies that might actively present oxygen-release to distinction native hypoxia in large-size constructs.

This evaluation offers an summary of the at the moment obtainable oxygen-releasing supplies and their synthesis and mechanism of motion, highlighting their capacities underneath in vitro tissue cultures and in vivo contexts. Additionally, we additionally showcase an rising idea, herein termed as “dwelling supplies as releasing techniques”, which depends on the mixture of biomaterials with photosynthetic microorganisms, particularly algae, in an “unconventional” try to produce the broken or re-growing tissue with the required provide of oxygen.

Prionace glauca pores and skin collagen bioengineered constructs as a promising strategy to set off cartilage regeneration

Representing a technique of marine by-products valorization, primarily based on isolation of biocompounds and evaluation of biomedical applicability, the potential of blue shark (Prionace glauca (PG)) pores and skin collagen to induce chondrogenic differentiation of human adipose stem cells (hASC) was investigated, with and with out exogenous stimulation. For that, a cryogelation methodology was utilized to supply extremely interconnected porous three-d (3D) constructs made of collagen and collagen:hyaluronic acid (20:1). In vitro research reveal that hASC adhere abundantly to the constructs which then suggests the early chondrogenic differentiation of these cells.

These findings are supported by the mRNA expression encoding chondrogenic-related markers like Coll II and Sox-9 which can be markedly upregulated at an early stage for each situations, with and with out exogenous stimulation. The introduction of hyaluronic acid (Hya) appears to play a essential function at later time factors, as proven by the evident immunodetection of aggrecan (ACAN), even with out exogenous stimulation. It is hypothesized that the PG collagen itself can help chondrogenic differentiation at early time factors, however exogenous stimulation is required to make sure phenotype upkeep. The current work highlights the relevance of utilizing blue shark collagen biopolymer as a constructing block to supply extremely efficient short-term matrices for cartilage functions.

 Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

L-histidine controls the hydroxyapatite mineralization with plate-like morphology: Effect of focus and media

Hydroxyapatite (HA) is the principle inorganic element of bone and dentin, and their non-stoichiometric compositions and plate-shaped morphology is accountable for their bioactivity and osteoconductive nature. Collagenous (CPs) and non-collagenous proteins (NCPs) facilitate mineralization and regulate structural properties of HA by means of their side-chains. The bioactivity of artificial HA doesn’t often match with the HA present in bone and, subsequently, there may be a want to know the function of biomolecules in bone mineralization with the intention to develop non-stoichiometric plate-shaped HA for bone grafts. Role of a number of amino acids has been investigated however the function of L-his has been not often investigated underneath physiological situations although it’s a half of HA inhibitor proteins, like albumin, amelogenin, and histidine-rich proteins.

Rat IgG2b Isotype Control

GWB-11EF45 0.5 mg Ask for price

Rat IgG2b Isotype Control

GWB-15EFE0 0.5 mg Ask for price

Rat IgG2b Isotype Control

GWB-1671C8 0.5 mg Ask for price

Rat IgG2b Isotype Control

GWB-1D8308 0.1 mg Ask for price

Rat IgG2b Isotype Control

GWB-6F4C48 0.1 mg Ask for price

Rat IgG2b Isotype Control

GWB-7A14AF 0.1 mg Ask for price

Rat IgG2b Isotype Control

GWB-F8EFA6 0.1 mg Ask for price

Rat IgG2b Isotype Control

GWB-EBB1F5 0.1 mg Ask for price

Rat IgG2b Isotype Control

GWB-DCB94C 0.1 mg Ask for price

Rat IgG2b Isotype Control

RIGG2BA-100 100 µg
EUR 391.97

Rat IgG2b Isotype Control

RIGG2BA-25 25 µg
EUR 199.78

Rat IgG2b Isotype Control

RIGG2BB-200 200 µg
EUR 549.22

Rat IgG2b Isotype Control

RIGG2BB-50 50 µg
EUR 269.66

Rat IgG2b Isotype Control

RIGG2BF-200 200 µg
EUR 566.69

Rat IgG2b Isotype Control

RIGG2BF-50 50 µg
EUR 182.3

Rat IgG2b Isotype Control

RIGG2BPE-100 100 µg
EUR 322.08

Rat IgG2b Isotype Control

RIGG2BPE-25 25 µg
EUR 182.3

Rat IgG2b Isotype Control

RIGG2BPP-100 100 µg
EUR 688.99

Rat IgG2b Isotype Control

RIGG2BPP-25 25 µg
EUR 322.08

Rat IgG2b Isotype Control

RIGG2BPP5.5-100 100 µg
EUR 619.1

Rat IgG2b Isotype Control

RIGG2BPP5.5-25 25 µg
EUR 339.55

Rat IgG2b Isotype Control

RIGG2BPU-50 50 µg
EUR 147.36

Rat IgG2b Isotype Control

RIGG2BPU-500 500 µg
EUR 444.38

Rat IgG2b Isotype Control

abx140594-100g 100 µg
EUR 250

Rat IgG2b Isotype Control

abx140595-100g 100 µg
EUR 250

Rat IgG2b Isotype Control

abx405051-200g 200 µg
EUR 275

Rat IgG2b Isotype Control

abx405053-200g 200 µg
EUR 200

Rat IgG2b Isotype Control PE

1P-169-C100 0.1mg
EUR 198

Rat IgG2b Isotype Control (PE)

abx405055-200g 200 µg
EUR 250

Rat IgG2b Isotype Control (PE)

abx347145-100l 100 µl Ask for price

Rat IgG2b Isotype Control (PE)

abx347145-50l 50 µl
EUR 350

Rat IgG2b Isotype Control (APC)

abx405049-100tests 100 tests
EUR 510

Rat IgG2b Isotype Control (RPE)

abx405055-100tests 100 tests
EUR 427.2

Rat IgG2b Isotype Control (APC)

abx405049-100g 100 µg
EUR 312.5

Rat IgG2b Isotype Control FITC

1F-169-C025 0.025 mg
EUR 82.5

Rat IgG2b Isotype Control FITC

1F-169-C100 0.1 mg
EUR 165

Rat IgG2b Isotype Control (FITC)

abx405052-01mg 0.1 mg
EUR 410.4

Rat IgG2b Isotype Control (FITC)

abx140596-100g 100 µg
EUR 300

Rat IgG2b Isotype Control (FITC)

abx405052-25g 25 µg
EUR 225

Rat IgG2b Isotype Control (Biotin)

abx405050-01mg 0.1 mg
EUR 376.8

Rat IgG2b Isotype Control (Biotin)

abx405050-100g 100 µg
EUR 212.5

Rat IgG2b Isotype Control Purified

11-169-C100 0.1 mg
EUR 115.5

PE Rat IgG2b, κ Isotype Control

DL22538F-20Tests 20Tests
EUR 158

PE Rat IgG2b, κ Isotype Control

DL22538F-50Tests 50Tests
EUR 233

PE Rat IgG2b, κ Isotype Control

DL22553F-25ug 25μg
EUR 137

PE Rat IgG2b, κ Isotype Control

DL22553F-50ug 50μg
EUR 182

PE rat IgG2b, κ Isotype Control

E16FRCP003K-025 25 tests
EUR 195
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control

E16FRCP003K-025U 25 μg
EUR 151.67
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control

E16FRCP003K-100 100 tests
EUR 346.67
Description: Available in various conjugation types.

PE rat IgG2b, κ Isotype Control

E16FRCP003K-100U 100 μg
EUR 325
Description: Available in various conjugation types.

APC Rat IgG2b, κ Isotype Control

DL22539F-20Tests 20Tests
EUR 170

APC Rat IgG2b, κ Isotype Control

DL22539F-50Tests 50Tests
EUR 245

APC Rat IgG2b, κ Isotype Control

DL22554F-25ug 25μg
EUR 147.5

APC Rat IgG2b, κ Isotype Control

DL22554F-50ug 50μg
EUR 197

APC rat IgG2b, κ Isotype Control

E16FRCA003K-025U 25 μg
EUR 173.33
Description: Available in various conjugation types.

APC rat IgG2b, κ Isotype Control

E16FRCA003K-100U 100 μg
EUR 411.67
Description: Available in various conjugation types.

FITC Rat IgG2b, κ Isotype Control

DL22537F-20Tests 20Tests
EUR 158

FITC Rat IgG2b, κ Isotype Control

DL22537F-50Tests 50Tests
EUR 233

FITC Rat IgG2b, κ Isotype Control

DL22552F-25ug 25μg
EUR 137

FITC Rat IgG2b, κ Isotype Control

DL22552F-50ug 50μg
EUR 182

FITC rat IgG2b, κ Isotype Control

E16FRCF003K-025 25 tests
EUR 130
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control

E16FRCF003K-050U 50 μg
EUR 151.67
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control

E16FRCF003K-100 100 tests
EUR 411.67
Description: Available in various conjugation types.

FITC rat IgG2b, κ Isotype Control

E16FRCF003K-200U 200 μg
EUR 628.33
Description: Available in various conjugation types.

PerCP Rat IgG2b, κ Isotype Control

DL22540F-20Tests 20Tests
EUR 185

PerCP Rat IgG2b, κ Isotype Control

DL22540F-50Tests 50Tests
EUR 267.5

AF488 Rat IgG2b, κ Isotype Control

DL22546F-20Tests 20Tests
EUR 185

AF488 Rat IgG2b, κ Isotype Control

DL22546F-50Tests 50Tests
EUR 267.5

AF647 Rat IgG2b, κ Isotype Control

DL22547F-20Tests 20Tests
EUR 185

AF647 Rat IgG2b, κ Isotype Control

DL22547F-50Tests 50Tests
EUR 267.5

PerCP Rat IgG2b, κ Isotype Control

DL22555F-25ug 25μg
EUR 182

PerCP Rat IgG2b, κ Isotype Control

DL22555F-50ug 50μg
EUR 272

AF488 Rat IgG2b, κ Isotype Control

DL22561F-25ug 25μg
EUR 182

AF488 Rat IgG2b, κ Isotype Control

DL22561F-50ug 50μg
EUR 272

AF647 Rat IgG2b, κ Isotype Control

DL22562F-25ug 25μg
EUR 182

AF647 Rat IgG2b, κ Isotype Control

DL22562F-50ug 50μg
EUR 272

PerCP rat IgG2b, κ Isotype Control

E16FRCR003K-025U 25 μg
EUR 325
Description: Available in various conjugation types.

PerCP rat IgG2b, κ Isotype Control

E16FRCR003K-100U 100 μg
EUR 780
Description: Available in various conjugation types.

Biotin Rat IgG2b, κ Isotype Control

DL22551F-25ug 25μg
EUR 137

Biotin Rat IgG2b, κ Isotype Control

DL22551F-50ug 50μg
EUR 182

Biotin rat IgG2b, κ Isotype Control

E16FRCB003K-200U 200 μg
EUR 606.67
Description: Available in various conjugation types.

Purified Rat IgG2b, κ Isotype Control

DL22550F-25ug 25μg
EUR 137

Purified Rat IgG2b, κ Isotype Control

DL22550F-50ug 50μg
EUR 182

Purified rat IgG2b, κ Isotype Control

E16FRCU003K-050U 50 μg
EUR 108.33
Description: Available in various conjugation types.

Rat IgG2b Isotype Control (Pacific Blue)

abx405054-100tests 100 tests
EUR 460.8

Rat IgG2b Isotype Control (Pacific Blue)

abx405054-200g 200 µg
EUR 275

Mouse IgG2b Isotype Control

abx139006-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx139011-01mg 0.1 mg
EUR 376.8

Mouse IgG2b Isotype Control

abx200580-100ug 100 ug
EUR 376.8

Mouse IgG2b Isotype Control

abx405056-100tests 100 tests
EUR 493.2

Mouse IgG2b Isotype Control

abx405061-1mg 1 mg
EUR 1296

Mouse IgG2b Isotype Control

E2790005 100ul
EUR 225
Description: Available in various conjugation types.

Mouse IgG2b Isotype Control

GWB-459550 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-1FD1D7 0.5 mg Ask for price

Mouse IgG2b Isotype Control

GWB-220C5B 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-1DCC96 100 TESTS Ask for price

Mouse IgG2b Isotype Control

ICIGG2BA-50 50 µg
EUR 231

Mouse IgG2b Isotype Control

ICIGG2BF-100 100 µg
EUR 126.5

Mouse IgG2b Isotype Control

ICIGG2BPE-50 50 µg
EUR 231

Mouse IgG2b Isotype Control

ICIGG2BPP-100 100 µg
EUR 253

Mouse IgG2b Isotype Control

ICIGG2BPP5.5-100 100 µg
EUR 253

Mouse IgG2b Isotype Control

ICIGG2BPU-100 100 µg
EUR 126.5

Mouse IgG2b Isotype Control

GWB-80FA28 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-813BD4 0.5 mg Ask for price

Mouse IgG2b Isotype Control

GWB-9266F5 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-4CF1B3 1 mg Ask for price

Mouse IgG2b Isotype Control

GWB-73DA51 0.5 mg Ask for price

Mouse IgG2b Isotype Control

GWB-788146 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-7EC042 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-B83C16 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-EFE90B 100 TESTS Ask for price

Mouse IgG2b Isotype Control

GWB-D5627B 100 TESTS Ask for price

Mouse IgG2b Isotype Control

abx139006-100l 100 µl
EUR 250

Mouse IgG2b Isotype Control

abx139006-500l 500 µl Ask for price

Mouse IgG2b Isotype Control

abx139011-100l 100 µl
EUR 250

Mouse IgG2b Isotype Control

abx139011-500l 500 µl Ask for price

Mouse IgG2b Isotype Control

abx405056-100g 100 µg
EUR 300

Mouse IgG2b Isotype Control

abx405061-100g 100 µg
EUR 937.5

Rat IgG2b Isotype Control LOW ENDOTOXIN

12-169-C100 0.1 mg
EUR 115.5

Rat IgG2b unconjugated (isotype control)

20005-13 100 ug
EUR 196.8

Rat IgG2b Isotype Control (PE) [LTF-2]

E2781876 100tests
EUR 485
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PE-Cy5 rat IgG2b, κ Isotype Control

E16FRCC003K-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

PE-Cy5 rat IgG2b, κ Isotype Control

E16FRCC003K-100U 100 μg
EUR 736.67
Description: Available in various conjugation types.

PE-Cy7 rat IgG2b, κ Isotype Control

E16FRCN003K-025U 25 μg
EUR 346.67
Description: Available in various conjugation types.

In this research, L-his and L-glu had been used to change the structural properties of HA in numerous experimental situations and buffer techniques (tris and hepes). The outcomes confirmed that L-his was in a position to regulate the plate-shaped morphology of HA in each experimental situation, in contrast to the L-glu, the place the crystal morphology was regulated by experimental situations. Both amino acids behaved in another way in DI water, tris, and hepes buffer, and the media used influenced the precipitation time and structural properties of HA.

Hepes and tris buffers additionally influenced the HA precipitation course of. Overall, the research revealed that L-his could also be used as an efficient regulator of plate-shaped morphology of HA, as a substitute of massive NCPs/proteins, for designing biomaterials for bone regeneration functions and the selection of buffer system is vital in designing and evaluating the techniques for mineralization. In cell tradition research, mouse osteoblast precursor cells (MC3T3-E1) confirmed highest proliferation on the bone-like plate-shaped HA, amongst all of the HA samples investigated.